Fei Cao
Chief Executive Officer chez HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Fortune : 288 223 $ au 31/03/2024
Profil
Fei Cao has held positions at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Jumpcan Pharmaceutical Co. Ltd.
His current job titles include Vice Chairman & General Manager at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Director at Jumpcan Pharmaceutical Co. Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
13/09/2022 | 1 961 500 ( 0,15% ) | 288 223 $ | 31/03/2024 |
Postes actifs de Fei Cao
Sociétés | Poste | Début |
---|---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 20/12/2019 |
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |